IAMAI Trademark

Trademark Overview

On Thursday, March 9, 2023, a trademark application was filed for IAMAI with the United States Patent and Trademark Office. The USPTO has given the IAMAI trademark a serial number of 97831342. The federal status of this trademark filing is FIRST EXTENSION - GRANTED as of Thursday, January 30, 2025. This trademark is owned by Xillix. The IAMAI trademark is filed in the Advertising, Business and Retail Services category with the following description:

Providing advertising and marketing services to the pharmaceutical and medical industries
iamai

General Information

Serial Number97831342
Word MarkIAMAI
Filing DateThursday, March 9, 2023
Status730 - FIRST EXTENSION - GRANTED
Status DateThursday, January 30, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 4, 2024

Trademark Statements

Goods and ServicesProviding advertising and marketing services to the pharmaceutical and medical industries

Classification Information

International Class035 - Advertising; business management; business administration; office functions.
US Class Codes100, 101, 102
Class Status Code6 - Active
Class Status DateWednesday, March 29, 2023
Primary Code035
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameXillix
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressNorth Cape May, NJ 08204
Party NameXillix
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressNorth Cape May, NJ 08204

Trademark Events

Event DateEvent Description
Monday, March 13, 2023NEW APPLICATION ENTERED
Thursday, October 12, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, December 6, 2023ASSIGNED TO EXAMINER
Wednesday, March 29, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, October 12, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, October 12, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, December 6, 2023NON-FINAL ACTION WRITTEN
Wednesday, December 6, 2023NON-FINAL ACTION E-MAILED
Wednesday, December 6, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, December 11, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, May 2, 2024ASSIGNED TO LIE
Thursday, May 2, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, May 2, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, May 2, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, May 15, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, July 30, 2024NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, January 21, 2025SOU TEAS EXTENSION RECEIVED
Thursday, January 30, 2025SOU TEAS EXTENSION RECEIVED
Thursday, January 30, 2025SOU EXTENSION 1 FILED
Tuesday, June 4, 2024PUBLISHED FOR OPPOSITION
Tuesday, June 4, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Thursday, January 30, 2025SOU EXTENSION 1 GRANTED
Friday, January 31, 2025NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, July 15, 2025ASSIGNED TO EXAMINER
Wednesday, July 30, 2025TEAS STATEMENT OF USE RECEIVED

Related Keywords

iamai medical industries pharmaceutical services advertising marketing providing